Skip to main content

Table 1 Patient demography and oncological outcome

From: Does preoperative percutaneous nephrostomy insertion worsen upper-tract urothelial cancer oncological outcome? A retrospective single center study

 

Preop PCN(+)

Preop PCN(−)

 

n = 25

n = 639

Gender(Male/Female)

11/14

366/273

0.189

Age(years)

70.8 ± 9.1

67.17 ± 10.8

0.098

Follow up duration

37.9 ± 27.8

48.6 ± 31.4

0.119

pT stage

  

0.353

 pT0

6

181

 

 pT1

10

174

 

 pT2

5

122

 

 pT3

3

154

 

 pT4

1

8

 

Papillary

18

506

0.378

Tumor location

 RP tumor

4

264

0.011

 U tumor

17

236

0.002

 RP + U tumor

4

138

0.790

High grade

23

578

0.796

LVI

6

97

0.232

CIS

7

226

0.449

Multifocal

9

189

0.491

TN

7

184

0.931

Smoking

5

65

0.116

ESRD

5

132

0.937

Prior bladder Ca

6

147

0.908

Oncological result

 Bladder recurrence

8

201

0.983

 Local recurrence

4

101

0.804

 Distant metastasis

1

96

0.201

 Cancer specific death

1

72

0.254

  1. RP tumor renal pelvis tumor, U tumor ureter tumor, LVI lymphovascular invasion
  2. CIS carcinoma in situ, TN tumor necrosis, ESRD end stage renal disease
Back to article page

BMC Urology

ISSN: 1471-2490

Contact us